Researchers are exploring the use of advanced nanomaterials for targeted therapy of myocardial ischemia-reperfusion injury. Various nanoparticle-based approaches are being investigated, including those that target inflammatory immune mechanisms and promote cardiac repair. The development of these nanotechnology-based treatments is ongoing, with studies focusing on different aspects of myocardial infarction treatment and therapy.